Conquering TB: A Step Closer to Achieving a TB-Free World
2 min read
Drug-resistant tuberculosis (TB) patients are now receiving medication for six months, rather than the previous year and a half to two years, thanks to improved drugs with fewer side effects. This change is not only beneficial for patients but also helps ease the strain on healthcare systems.
The new drugs have fewer side effects, such as permanent deafness and psychiatric disorders, which were common with the previous treatment. This improvement has encouraged more people to complete their treatment, leading to better outcomes for TB patients.
The Global Fund to Fight AIDS, Tuberculosis, and Malaria is playing a crucial role in providing access to these improved drugs in countries with high TB prevalence. The fund covers the cost of medications, making it easier for patients to access and complete their treatment.
However, the sustainability of these programs largely depends on the support of donors. TB treatment is expensive, with the recommended treatment costing at least $150 per patient in low- and middle-income countries. Without sufficient financial support, it would be challenging to ensure affordable access to medication for TB patients.
To address this issue, Johnson & Johnson, a leading pharmaceutical company, has taken an important step. They have lowered the price of a key TB drug in certain developing countries. Additionally, the company agreed not to enforce a patent, allowing generic drug companies to produce cheaper versions of the medication.
Affordable access to TB medication is crucial for patients to continue their treatment and prevent the spread of the disease. The actions taken by Johnson & Johnson are commendable and will have a significant impact on enhancing accessibility and affordability.
In conclusion, the availability of improved drugs and the support of organizations like the Global Fund to Fight AIDS, Tuberculosis, and Malaria, along with the efforts made by companies like Johnson & Johnson, are crucial steps in the fight against drug-resistant TB. However, sustained donor support is essential to ensure the sustainability of these programs and to guarantee affordable access to medication for TB patients worldwide.
“Musicaholic. Thinker. Extreme travel trailblazer. Communicator. Total creator. Twitter enthusiast.”
